These global and U.S. stocks are set to soar further after a strong first half, analysts say

  • 📰 CNBC
  • ⏱ Reading Time:
  • 47 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 72%

Canada News News

Canada Canada Latest News,Canada Canada Headlines

CNBC Pro screened for stocks that are loved by analysts and expected to continue to outperform, with major upside potential.

U.S. and global stocks rallied in the first half of this year, but with sticky inflation, continued Fed rate hikes, and the possibility of a recession on the horizon, the outlook for the rest of 2023 looks uncertain. The S & P 500 soared by 15.9% in the first six months of the year — its best first half since 2019. The MSCI World Index , meanwhile, was up over 12%.

Pro screened for U.S. and global stocks that are among the top performers over the year to date -- up over 15% — with an average analyst price target that implies upside of at least 30% over the next 12 months. All of the stocks have a buy rating from at least 60% of analysts covering them. EV makers BYD and Stellantis both made the list, gaining over 20% each in the first half. They are also well-loved by analysts, with a more-than 70% buy rating and over 30% potential upside.

Pro's screen, with 32% potential upside and a 74% buy rating. Morgan Stanley was bullish on the Chinese Internet services giant in a June note, calling it the best AI play in China and the "most obvious beneficiary" of the $7.4 trillion AI opportunity in country. Super Hi International Holding was the top performer on the screen, with a 52.7% gain in the first half, and the only stock with a 100% buy rating.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in CA

Canada Canada Latest News, Canada Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Take-Two, this drug name are among the most overbought stocks on Wall Street. Here are the othersCNBC Pro screened for the most overbought and oversold stocks.
Source: CNBC - 🏆 12. / 72 Read more »

CNBC Daily Open: Tesla roars in a quiet marketTesla set off fireworks on a quiet trading day shortened for the Fourth of July holiday.
Source: CNBC - 🏆 12. / 72 Read more »

Global stocks had a strong start to 2023. Here's where they will go next, according to historyWith investors in global stocks bagging stellar returns already, CNBC Pro examines whether there is room for growth in the second half of 2023.
Source: CNBC - 🏆 12. / 72 Read more »

Most patriotic stocks: These names can benefit the most from a strong U.S. economyCNBC Pro set out to find the stocks that can capitalize the most from a strong U.S. economy.
Source: CNBC - 🏆 12. / 72 Read more »